Utah Medical Products INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Utah Medical Products Inc. reported a decline in 2025 revenues and net income, impacted by lost OEM sales and Filshie Clip litigation, despite maintaining strong cash reserves.
NASDAQ
Utah Medical Products Inc. experienced a significant decrease in worldwide revenues and net income in 2024, primarily due to reduced OEM sales, declining Filshie clip sales, and ongoing product liability litigation.
NASDAQ
Utah Medical Products experienced a decrease in revenue but an increase in net income for 2023, while anticipating a significant revenue decline in 2024 due to reduced OEM sales and other factors.